Evaluating the Cologuard Test for Use in Lynch Syndrome

ABSTRACT: This study is aiming to enroll 90 patients with genetically confirmed Lynch Syndrome (LS) from Geisinger’s High Risk Colorectal Cancer Clinic (HRC). Upon enrollment in the study, a Cologuard test will be ordered and the results will be blinded until data analysis. Patients enrolled in the study will also undergo a colonoscopy as part of their routine HRC visit.

DISEASE(S): Colonic Adenoma,Colonic Polyps,Lynch Syndrome,Colorectal Cancer,Colorectal Neoplasms,Colonic Polyp,Adenoma,Colorectal Neoplasms, Hereditary Nonpolyposis

PROVIDER: 2369214 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR